Skip to content
Licensed Unlicensed Requires Authentication Published by De Gruyter April 4, 2023

Acetylcholine receptor and muscle-specific tyrosine kinase antibodies detection: is it time for a change?

  • Danilo Villalta ORCID logo EMAIL logo , Martina Fabris ORCID logo , Lorenzo Verriello ORCID logo , Francesca Grizzo ORCID logo , Emanuela Maria Mobilia ORCID logo , Anastasia Lechiara ORCID logo and Giampaola Pesce ORCID logo

Corresponding author: Danilo Villalta, MD, Department of Immunology and Allergy, S. Maria degli Angeli Hospital, 24 Via Montereale, Pordenone 33170, Italy, Phone: +39-0434-399647, E-mail:

  1. Research funding: None declared.

  2. Author contributions: All authors have accepted responsibility for the entire content of this manuscript and approved its submission.

  3. Competing interests: Authors state no conflict of interest.

  4. Informed consent: Informed consent was obtained from all individuals included in this study.

  5. Ethical approval: The local Institutional Review Board deemed the study exempt from review.

References

1. Lazaridis, K, Tzartos, SJ. Myastenia gravis: autoantibody specificities and their role in MG management. Front Neurol 2020;11:596981. https://doi.org/10.3389/fneur.2020.596981.Search in Google Scholar PubMed PubMed Central

2. Lindstrom, J. An assay for antibodies to human acetylcholine receptor in serum from patients with myasthenia gravis. Clin Immunol Immunopathol 1977;7:36–43. https://doi.org/10.1016/0090-1229(77)90027-7.Search in Google Scholar PubMed

3. Matthews, I, Chen, S, Hewer, R, McGrath, V, Furmaniak, J, Rees Smith, B. Muscle-specific receptor tyrosine kinase autoantibodies-a new immunoprecipitation assay. Clin Chim Acta 2004;348:95–9. https://doi.org/10.1016/j.cccn.2004.05.008.Search in Google Scholar PubMed

4. Leite, MI, Jacob, S, Viegas, S, Cossins, J, Clover, L, Morgan, BP, et al.. IgG1 antibodies to acetylcholine receptors in ‘seronegative’ myasthenia gravis. Brain 2000;131:1940–52. https://doi.org/10.1093/brain/awn092.Search in Google Scholar PubMed PubMed Central

5. Tsonis, AI, Zisimopoulou, P, Lazaridis, K, Tzartos, J, Matsigkou, E, Zouvelou, V, et al.. MuSK autoantibodies in myasthenia gravis detected by cell based assay-a multinational study. J Neuroimmunol 2015;284:10–7. https://doi.org/10.1016/j.jneuroim.2015.04.015.Search in Google Scholar PubMed

6. Mirian, A, Nicolle, MW, Edmond, P, Budhram, A. Comparison of fixed cell-based assay to radioimmunoprecipitation assay for acetylcholine receptor antibody detected in myasthenia gravis. J Neurol Sci 2022;432:120084. https://doi.org/10.1016/j.jns.2021.120084.Search in Google Scholar PubMed

7. Spagni, G, Gastaldi, M, Businaro, P, Chemkhi, Z, Carrozza, C, Mascagna, G, et al.. Comparison of fixed and live cell-based assay for the detection of AChR and MuSK antibodies in myasthenia gravis. Neurol Neuroimmunol Neuroinflammation 2022;10:200038. https://doi.org/10.1212/nxi.0000000000200038.Search in Google Scholar PubMed PubMed Central

8. Martino, G, Twaddle, G, Brambilla, E, Grimaldi, LM. Detection of anti-acetylcholine receptor antibody by an ELISA using human receptor from rhabdomyosarcoma cell line. Acta Neurol Scand 1994;89:18–22. https://doi.org/10.1111/j.1600-0404.1994.tb01626.x.Search in Google Scholar PubMed

9. Hever, R, Matthews, I, Chen, S, McGrath, V, Evans, M, Roberts, E, et al.. A sensitive non-isotopic assay for acetylcholine receptor antibodies. Clin Chim Acta 2006;364:159–66.10.1016/j.cccn.2005.05.035Search in Google Scholar PubMed

10. Gastaldi, M, Scaranzin, S, Busunaro, P, Mobilia, E, Benedetti, L, Pesce, G, et al.. Improving laboratory diagnostics in myasthenia gravis. Expert Rev Mol Diagn 2021;21:579–90. https://doi.org/10.1080/14737159.2021.1927715.Search in Google Scholar PubMed

Received: 2023-02-26
Accepted: 2023-03-27
Published Online: 2023-04-04
Published in Print: 2023-09-26

© 2023 Walter de Gruyter GmbH, Berlin/Boston

Downloaded on 8.5.2024 from https://www.degruyter.com/document/doi/10.1515/cclm-2023-0205/html
Scroll to top button